No Data
Express News | Shares of Eagle Pharmaceuticals Hit Session High of $5.13 in Volume Jump, Last up 9.9% at $5.00
Express News | Eagle Pharmaceuticals Inc Says on May 28, Co Requested Hearing Before Hearings Panel of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Eagle Pharmaceuticals Shares Are Trading Lower After the Company Announced a Nasdaq Listing Receipt.
Eagle Pharmaceuticals Shares Are Trading Lower After the Company Announced a Nasdaq Listing Receipt.
Express News | Eagle Pharmaceuticals Announces Receipt of Delisting Notification From Nasdaq
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks eased late Monday afternoon, with the NYSE Health Care Index decreasing 0.1% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. The iShares Biotechnology ETF (IBB) fell 1.
Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise
Eagle Pharmaceuticals (EGRX) shares climbed 9% in recent trading after the company said Monday that it will present phase III trial data showing that intravenous amisulpride may sustain an antiemetic